期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Nonalcoholic fatty liver disease (NAFLD) is becoming the most frequent chronic liver disease worldwide. Metabolic (dysfunction) associated fatty liver......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Background and purpose: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) - one of the mos......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Purpose: The aim of the study was to explore the correlation between serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabete......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Objective: The metrics generated from continuous glucose monitoring (CGM), such as time in range (TIR), are strongly correlated with diabetes complica......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Background: In recent years, many studies have reported the relationship between non-alcoholic fatty liver disease (NAFLD) and sex hormones, especiall......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Background: Evidence investigating sleep pattern in relation to bone health in elderly participants with osteoporosis remains sparse. We aimed to asse......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
This study seeks to evaluate the effects of a reversal of sedentary lifestyles on the improvement of metabolic profiles in patients with NAFLD. The Pu......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022; 13 ()
Background: Thyroid cancer has become increasingly prevalent and threatens human health. Few studies have explored the incidence of thyroid cancer in ......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021; 12 ()
Background: The number of patients > 65 years who require maintenance hemodialysis (MHD) is increasing. Although reduced bone turnover in older pat......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021; 12 ()
Background: Patients with type 2 diabetes mellitus (T2DM) have an elevated risk of atherosclerotic cardiovascular disease. Although previous data have......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020; 11 ()
Efforts directed toward restoring normal metabolic levels by mimicking the physiological insulin secretion, thereby ensuring safety, efficacy, minimal......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020; 11 ()
Background: Implantation is initiated when the blastocyst attaches to the endometrium during the peri-implantation period, and appropriate neovascular......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020; 11 ()
Objective: Some studies have shown that metformin can reduce body weight. However, metformin has not been officially approved as a medicine for weight......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020; 11 ()
Aims: Toll-like receptor 4 (TLR4) and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB3) are involved in the progress of inflammation and gl......
期刊： THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020; 11 ()
Aims: Our aim was to investigate the impact of glycemic variability (GV) on the relationship between glucose management indicator (GMI) and laboratory......
